General assay for phosphoproteins in cerebrospinal fluid: A candidate market for paraneoplastic cerebellar degeneration
- 1 December 1990
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 28 (6) , 829-833
- https://doi.org/10.1002/ana.410280616
Abstract
The components of protein phosphorylation systems (protein kinases, protein phosphatases, and their phosphoprotein substrates) are highly enriched in neuronal cells compared with other cell types. We exploited this relative neuronal enrichment of protein phosphorylation system components to develop a general assay technique for putative protein kinase substrates (phosphoproteins) in human cerebrospinal fluid. Using this cerebrospinal fluid phosphoprotein assay, we have detected a putative protein kinase C substrate protein of apparent Mr 60 kd in 6 of 14 patients with paraneoplastic cerebellar degeneration but not in any of 55 patients with a variety of other neurological diseases. Phosphoproteins in cerebrospinal fluid may provide novel and unique markers for the diagnosis or staging of neuronal diseases as well as offer potential insights into the biochemical characterization of affected neuronal populations.This publication has 6 references indexed in Scilit:
- Paraneoplastic cerebellar degeneration: Clinical‐immunological correlationsAnnals of Neurology, 1988
- The metabolic anatomy of paraneoplastic cerebellar degenerationAnnals of Neurology, 1988
- Neuronal phosphoproteinsMolecular Neurobiology, 1987
- PCPP-260, a Purkinje cell-specific cyclic AMP-regulated membrane phosphoprotein of Mr 260,000Journal of Neuroscience, 1986
- Inhibition by calmodulin of calcium/phospholipid-dependent protein phosphorylation.Proceedings of the National Academy of Sciences, 1984
- Microinjection of catalytic subunit of cyclic AMP-dependent protein kinase enhances calcium action potentials of bag cell neurons in cell cultureProceedings of the National Academy of Sciences, 1980